Search for: "PFIZER" Results 3701 - 3720 of 4,635
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 May 2021, 2:01 pm by Matt Gluck
  The EU’s drug regulator on Friday authorized the Pfizer-BioNTech coronavirus vaccine for use in children between the ages of 12 and 15, writes France24. [read post]
15 Aug 2021, 5:54 pm by lcampbell@lawbc.com
., Chair Affiliation:  Former Senior Research Fellow (Retired), Pfizer Global Research and Development, Groton, Connecticut Expertise: In vitro predictive toxicology; pre-conception reproductive toxicology Education: Ph.D., Pharmacology, University of North Carolina, Chapel Hill; B.A., Biology, Earlham College Veronica, J. [read post]
21 Jan 2015, 3:02 pm
Its corporate talking heads (Bristol-Myers Squibb and Pfizer) said such spending helps ensure that providers understand its appropriate use, and how important it is “to have a speaker program that adequately provides robust education to these physicians. [read post]
16 Sep 2020, 11:15 am by Anna Salvatore
At this point, it is unclear when a vaccine will be available, but drug giant Pfizer says it may ask for emergency authorization as soon as October. [read post]
3 Aug 2021, 11:43 am by Ajay Sarma, Christiana Wayne
President Biden has promised that the U.S. will be an “arsenal of vaccines” for the world and made a pledged to ship 500 million doses of the Pfizer vaccine to 100 low-income countries by June 2022. [read post]
20 Jan 2016, 12:47 pm by Daniel Shaviro
., involving companies in the same industry - such as Burger King and Tim Horton's, or Pfizer and Allergan. [read post]
22 Sep 2021, 12:45 pm by Emily Dai
” Biden announced on Wednesday that the U.S. will buy another 500 million doses of Pfizer’s coronavirus vaccine to donate to low-income and lower-middle-income countries, according to Bloomberg. [read post]
13 Jan 2020, 12:04 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
5 Nov 2021, 12:06 pm by Emily Dai
  Pfizer announced Friday that its experimental antiviral pill for the coronavirus cut the risk of hospitalization and death by nearly 90 percent in a study of 775 high-risk adults, according to AP News. [read post]
5 Jul 2015, 12:59 pm
AstraZeneca, Pfizer and Allergan were other big spenders in the category of general payments. [read post]
29 Mar 2022, 10:06 am by Katherine Pompilio
FDA officials report that, “Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk individuals. [read post]
7 Dec 2020, 8:40 am by Jon L. Gelman
 On December 10, 2020, the Center for Biologics Evaluation and Research's (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older. [read post]
4 Apr 2017, 1:55 am
Eleonora Rosati calls for readers’ attention on the new event organised by TIPLO (The Intellectual Property Lawyers Organisation) in London on March 28, 2017.Last but not least, the weekly routines that bring round-ups for the latest IP happenings including events, book release and highlighted blog posts: Never too Late (here ,here and here), Friday Fantasies and Around the IP Blogs (and here) by InternKats Verónica Rodríguez Arguijo, Hayleigh Bosher and Tian… [read post]
31 Aug 2022, 1:51 pm by Hadley Baker, Matt Gluck, Claudia Swain
Pfizer and Moderna have each been approved to administer one such booster shot. [read post]
30 Jul 2013, 1:06 pm
David Perla, Pangea3 Marla Persky, Baxter Healthcare Corporation Jerome Rubin, LexisNexis Amy Schulman, Pfizer Inc. [read post]